Market observers will be monitoring the actions of pre-IPO investors and promoters in firms such as Mankind Pharma, Kaynes Technologies, Gland Pharma, Utkarsh Small Finance Bank and Senco Gold, among others, to ascertain whether they opt to divest or maintain their current holdings.
Tata Sons boardroom battle intensifies but Tata Group stocks remain unbothered. Should you buy?
Tata Sons has rejected Noel Tata’s objections to N Chandrasekaran’s reappointment, saying the board’s decision was valid and made in accordance with the company’s Articles